Source: Streetwise Reports 09/12/2022 One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving...
The FDA has started a priority review of Chiesi ‘s velmanase alfa, an enzyme replacement therapy for lysosomal The post FDA starts review of first drug...
The article Algernon Pharmaceuticals Receives Approval for Phase 1 DMT Study was originally published on Microdose. For more on Algernon and their DMT...
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...
Whether you’re a seasoned trader making money with penny stocks or just… The post Penny Stocks To Buy: The Good, Bad, & Ugly & 3 To...
Psychologist Ralph Hood’s study of serpent handling and mysticism helped legitimize the study of psychedelics. So why doesn't he want them approved for...
The article MindMed Faces Tough IP Questions (and Publishes Positive Trial Results) was originally published on Microdose. MindMed’s been in the news...
The article The Medicalization of Sacred Plant Medicines was originally published on Microdose. Like many, I’ve watched the recent resurgence of interest...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD | NEO: MMED), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders,...
The article A Deeper Look at Ketamine for Alcohol Use Disorder was originally published on Microdose. In the last decades, there has been a growing interest...